COPD - management

Difficult to manage COPD Exacerbations: Risk factors (DIMECO Study). Turkish Thoracic Society COPD Assembly
Ayşe Baha, Nurdan Kokturk, Dilek Yapar, Secil Ozkan, Elif Sen, Fatma Ciftci, Burcu Ozturk, Sumeyye Kodalak, Gaye Ulubay, Irem Serifoglu, Yelda Varol, Aydan Mertoglu, Ali Kadri Cirak, Onur Turan, Nese Dursunoglu, Nilufer Savurmus, Alev Gurgun, Funda Elmas, Lutfi Coplu, Umran Sertcelik, Reyhan Yildiz, Ipek Ozmen, Aylin Alpaydin, Mehmet Polatli, Ebru Karacay Yesiloglu, Deniz Celik

European Respiratory Journal Sep 2020, 56 (suppl 64) 4915; DOI: 10.1183/13993003.congress-2020.4915
Clinical efficacy of the COPDnet integrated care model
Alex J Van 't Hul, Noortje Koolen, Philip Van Der Wees, Gert Westert, Jeanine Antons, Marianne De Man, Richard Dekhuijzen, Michel Van Den Heuvel

European Respiratory Journal Sep 2020, 56 (suppl 64) 5177; DOI: 10.1183/13993003.congress-2020.5177
Oxygen consumption (V?O2) kinetics during recovery after resistance exercises in COPD and matched controls
Andre Nyberg, Lori Desroches, Erik Frykholm, Didier Saey, Mickael Martin, Francois Maltais

European Respiratory Journal Sep 2020, 56 (suppl 64) 4745; DOI: 10.1183/13993003.congress-2020.4745
Predictive modelling of COPD exacerbation rates using baseline risk factors
Dave Singh, Fernando J. Martinez, Klaus F. Rabe, John R. Hurst, Mona Bafadhel, Martin Jenkins, Paul Dorinsky, Patrick Darken

European Respiratory Journal Sep 2020, 56 (suppl 64) 5235; DOI: 10.1183/13993003.congress-2020.5235
Budesonide/formoterol maintenance and reliever therapy versus fluticasone/salmeterol fixed-dose treatment in patients with COPD
Susan Muiser, Bart Luijk, Gert-Jan Braunstahl, Irene Heijink, Helen Reddel, Huib Kerstjens, Maarten Van Den Berge

European Respiratory Journal Sep 2020, 56 (suppl 64) 5237; DOI: 10.1183/13993003.congress-2020.5237
Late Breaking Abstract - COPD exacerbation benefits relative to pneumonia risk with budesonide/glycopyrronium/formoterol metered dose inhaler: analyses from ETHOS
Klaus F. Rabe, Fernando J. Martinez, Gary T. Ferguson, Dave Singh, Jadwiga A. Wedzicha, Martin Jenkins, Magnus Aurivillius, Colin Reisner, Paul Dorinsky

European Respiratory Journal Sep 2020, 56 (suppl 64) 5230; DOI: 10.1183/13993003.congress-2020.5230
Sing-a-Lung: Group singing as training modality in pulmonary rehabilitation for patients with Chronic Obstructive Pulmonary Disease (COPD): A multicenter, cluster-randomised, non-inferiority controlled trial
Mette Kaasgaard, Daniel Bech Rasmussen, Anders Løkke Ottesen, Peter Vuust, Ole Hilberg, Uffe Bodtger

European Respiratory Journal Sep 2020, 56 (suppl 64) 4663; DOI: 10.1183/13993003.congress-2020.4663
Underappreciation of coronary artery disease in patients with COPD
Christoph Beyer, Alex Pizzini, Anna Boehm, Judith Loeffler-Ragg, Guenter Weiss, Gudrun Feuchtner, Axel Bauer, Guy Friedrich, Fabian Plank

European Respiratory Journal Sep 2020, 56 (suppl 64) 5116; DOI: 10.1183/13993003.congress-2020.5116
Promising integrated care platform developed with and tested by respiratory patients: lessons learned form the European H2020 Connecare study
Esther I. Metting, Maarten M.H. Lahr

European Respiratory Journal Sep 2020, 56 (suppl 64) 4800; DOI: 10.1183/13993003.congress-2020.4800
Seasonal variation in COPD exacerbation rates: budesonide/glycopyrronium/formoterol metered dose inhaler (BGF MDI) at two ICS dose levels in the ETHOS trial
Gary T. Ferguson, Klaus F. Rabe, Fernando J. Martinez, Chen Wang, Dave Singh, Jadwiga A. Wedzicha, Roopa Trivedi, Earl St Rose, Shaila Ballal, Julie Mclaren, Patrick Darken, Magnus Aurivillius, Colin Reisner, Paul Dorinsky

European Respiratory Journal Sep 2020, 56 (suppl 64) 5238; DOI: 10.1183/13993003.congress-2020.5238

Main menu

User menu

Search

COPD - management

Pages

Contact us